These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2938025)

  • 21. Modulation of [3H]paroxetine binding to the 5-hydroxytryptamine uptake site in an animal model of depression.
    Edwards E; Harkins K; Wright G; Henn F
    J Neurochem; 1991 May; 56(5):1581-6. PubMed ID: 1826517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo labeling of serotonin uptake sites with [3H]paroxetine.
    Scheffel U; Hartig PR
    J Neurochem; 1989 May; 52(5):1605-12. PubMed ID: 2523469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains.
    Rosel P; Arranz B; Vallejo J; Oros M; Crespo JM; Menchon JM; Navarro MA
    Psychiatry Res; 1998 Jun; 82(3):161-70. PubMed ID: 9754440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solubilization and characterization of [3H]imipramine and [3H]paroxetine binding sites from calf striatum.
    Rotondo A; Giannaccini G; Quattrone C; Marazziti D; Martini C; Cassano GB; Lucacchini A
    Neurochem Res; 1994 Oct; 19(10):1295-300. PubMed ID: 7891847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
    De Souza EB; Kuyatt BL
    Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further studies on platelet serotonin transporter binding in depression.
    Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
    Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characteristics of 3H-paroxetine-labeled serotonin uptake sites in rat brain].
    Yoshida Y
    Yakubutsu Seishin Kodo; 1988 Jun; 8(2):345-57. PubMed ID: 2975437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced displacement of [3H]imipramine, but not [3H]paroxetine binding by plasma from depressed patients.
    Lawrence KM; Lowther S; Falkowski J; Jacobson RR; Horton RW
    J Affect Disord; 1997 Nov; 46(2):127-34. PubMed ID: 9479616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The activity of 25 paroxetine/femoxetine structure variants in various reactions, assumed to be important for the effect of antidepressants.
    Plenge P; Mellerup ET; Honoré T; Honoré PL
    J Pharm Pharmacol; 1987 Nov; 39(11):877-82. PubMed ID: 2892909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders.
    Marcusson JO; Alafuzoff I; Bäckström IT; Ericson E; Gottfries CG; Winblad B
    Brain Res; 1987 Nov; 425(1):137-45. PubMed ID: 3427415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet [3H]paroxetine binding to 5-HT uptake sites in Alzheimer's disease.
    Andersson A; Adolfsson R; Eriksson K; Marcusson J
    Neurobiol Aging; 1991; 12(5):531-4. PubMed ID: 1837595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug inhibition indicates a single-site model of the 5-HT uptake site/antidepressant binding site in rat and human brain.
    Marcusson JO; Andersson A; Bäckström I
    Psychopharmacology (Berl); 1989; 99(1):17-21. PubMed ID: 2528778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High- and low-affinity binding of [3H]imipramine in rat hypothalamus.
    Moret C; Briley M
    J Neurochem; 1986 Nov; 47(5):1609-13. PubMed ID: 2944992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography.
    Appel NM; Mitchell WM; Contrera JF; De Souza EB
    Synapse; 1990; 6(1):33-44. PubMed ID: 2144664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imipramine binding site. Temperature dependence of the binding of 3H-labeled imipramine and 3H-labeled paroxetine to human platelet membrane.
    Plenge P; Mellerup ET
    Biochim Biophys Acta; 1984 Feb; 770(1):22-8. PubMed ID: 6230106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum.
    Kaufman MJ; Madras BK
    Synapse; 1991 Sep; 9(1):43-9. PubMed ID: 1796351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring the serotonin uptake site using [3H]paroxetine--a new serotonin uptake inhibitor.
    Gleiter CH; Nutt DJ
    Adv Alcohol Subst Abuse; 1988; 7(3-4):107-11. PubMed ID: 2975918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific binding sites for cyclic antidepressants.
    Mellerup ET; Plenge P
    Acta Pharmacol Toxicol (Copenh); 1985; 56 Suppl 1():154-61. PubMed ID: 2984884
    [No Abstract]   [Full Text] [Related]  

  • 39. Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease.
    Cross AJ; Slater P; Reynolds GP
    Neurosci Lett; 1986 Jun; 67(2):198-202. PubMed ID: 2873534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [3H]imipramine labels sites on brain astroglial cells not related to serotonin uptake.
    Whitaker PM; Vint CK; Morin R
    J Neurochem; 1983 Nov; 41(5):1319-23. PubMed ID: 6619868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.